News

Two new JAMA Network Open studies link popular diabetes and weight loss drugs, including Ozempic and Mounjaro, to a slightly ...
As weight-loss drugs are gaining popularity among Indian diabetes and obesity stricken patients in India, new research ...
If Novo Nordisk A/S’s wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer’s disease, Biogen Inc.’s Chief Executive Officer Chris Viehbacher doesn’t see it as a ...
Over-the-counter (OTC) medicines promise quick relief, but when used frequently and without medical supervision, they can ...